GLP-2TZ Research Compound

GLP-2TZ is a synthetic peptide analog that has been investigated in preclinical laboratory research for its interaction with key receptors involved in metabolic signaling pathways. Specifically, it targets the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. These receptors are found in various mammalian tissues and play a role in cellular communication and metabolic function.

GLP-2TZ is studied as a dual agonist at the GIP and GLP-1 receptors. Published work characterises its receptor binding and incretin signalling.

Handle as a laboratory research chemical of unknown hazard. Use gloves and eye protection, avoid inhalation of the lyophilized powder, and follow standard laboratory handling procedures.

Reconstitute and store according to the product label. Lyophilized material should be kept cool, dry and protected from light; reconstituted material should be held at 2-8°C and protected from light.

The safety profile of GLP-2TZ has not been established. This compound is supplied for laboratory research use only and is not approved for human or veterinary use.

GLP-2TZ is a synthetic peptide analog studied in preclinical models for its interaction with GIP and GLP-1 receptors, which are central to metabolic and hormonal signaling pathways. Laboratory research has examined its effects on glucose metabolism, insulin signaling, and endocrine regulation. These investigations are performed in non-human or in vitro settings and do not represent established safety or effects in humans. Ongoing research continues to evaluate its biological activity across metabolic and endocrine studies.